Study of The Possible Effect of Fluoxetine, Moringa Oleifera and Methotrexate in A Rat Model Of Rheumatoid Arthritis
Mansour, M., Sherif, M., Ismail, Y., Abd Elhameed, A., Awad, S. (2022). Study of The Possible Effect of Fluoxetine, Moringa Oleifera and Methotrexate in A Rat Model Of Rheumatoid Arthritis. EKB Journal Management System, 39(Special issue (Academic)), 35-51. doi: 10.21608/bmfj.2021.56364.1365
Mohamed Mansour; Mohie Sherif; Yasmeen Ismail; Abeer Abd Elhameed; Sara Awad. "Study of The Possible Effect of Fluoxetine, Moringa Oleifera and Methotrexate in A Rat Model Of Rheumatoid Arthritis". EKB Journal Management System, 39, Special issue (Academic), 2022, 35-51. doi: 10.21608/bmfj.2021.56364.1365
Mansour, M., Sherif, M., Ismail, Y., Abd Elhameed, A., Awad, S. (2022). 'Study of The Possible Effect of Fluoxetine, Moringa Oleifera and Methotrexate in A Rat Model Of Rheumatoid Arthritis', EKB Journal Management System, 39(Special issue (Academic)), pp. 35-51. doi: 10.21608/bmfj.2021.56364.1365
Mansour, M., Sherif, M., Ismail, Y., Abd Elhameed, A., Awad, S. Study of The Possible Effect of Fluoxetine, Moringa Oleifera and Methotrexate in A Rat Model Of Rheumatoid Arthritis. EKB Journal Management System, 2022; 39(Special issue (Academic)): 35-51. doi: 10.21608/bmfj.2021.56364.1365

Study of The Possible Effect of Fluoxetine, Moringa Oleifera and Methotrexate in A Rat Model Of Rheumatoid Arthritis

Benha Medical Journal
Article 177, Volume 39, Special issue (Academic), September and October 2022, Page 35-51  XML PDF (1.31 MB)
Document Type: Original Article
DOI: 10.21608/bmfj.2021.56364.1365
View on SCiNiTO View on SCiNiTO
Authors
Mohamed Mansour1; Mohie Sherif1; Yasmeen Ismail2; Abeer Abd Elhameed2; Sara Awad email 3
1Professor of clinical Pharmacology Faculty of Medicine, Banha University
2Lecturer of clinical Pharmacology Faculty of Medicine, Banha University
3Demonstrator in The Department of Clinical Pharmacology, Faculty of Medicine, Benha University.
Abstract
Background: Rheumatoid arthritis (RA) is a chronic, relapsing inflammatory and autoimmune multisystem disease that affects the joints. Methotrexate (MTX) is considered by many rheumatologists to be the most important and useful disease-modifying antirheumatic drugs (DMARDs). Fluoxetine is a selective serotonin reuptake inhibitor that has been widely used for the treatment of depression due to its safer profile. Moringa oleifera (MO) is known for its nutritional and medicinal uses. Various parts of these plant act as cardiac and circulatory stimulants. The present study was designed to evaluate the possible effect of methotrexate, Fluoxetine and Moringa Oleifera on rat model of RA. Materials and methods: Rats were classified into: Group I: control normal group. Group II: was not treated (diseased group). Group III: was treated with methotrexate (MTX) (0. 6 mg/kg/week/by oral gavage). Group IV: was treated with fluoxetine (20 mg/kg/day by oral gavage) Group V: was treated with Moringa Oleifera extract (200 mg/kg/day by oral gavage). Treated groups received drugs for 4 weeks. Results: Treated groups showed significant improvement in all parameters (rheumatoid factor (RF), tumor necrosis factor alpha (TNF-α), C-reactive protein (CRP), reduced glutathione (GSH), anti-cyclic citrullinated peptide (anti-CCP), arthritis score).and improvement of the histopathology of the joint. A significant reduction in the score was seen in the treated group at the end of 3rd and 4th weeks. With best results in Moringa Oleifera group in comparison with other treated groups. Conclusion: Methotrexate, fluoxetine and Moringa Oleifera extract groups showed significant improvement of parameters of RA.
Keywords
Rheumatoid arthritis; methotrexate; fluoxetine; Moringa Oleifera; adjuvant-induced arthritis
Statistics
Article View: 530
PDF Download: 720